SCHEDULE OF OPTIONS OUTSTANDING (Details) |
12 Months Ended |
|---|---|
|
Dec. 31, 2025
$ / shares
shares
| |
| Equity [Abstract] | |
| Options Exercisable | shares | 237,741,665 |
| Weighted Average Exercise Price of Options Exercisable | $ / shares | $ 0.05 |
| Weighted Average Contractual Life of Options Exercisable (Years) | 3 years 6 months 7 days |
| Weighted Average Contractual Life of Options Outstanding (Years) | 3 years 7 months 13 days |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|